日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

更正：克拉屈滨片剂治疗复发型多发性硬化症患者的血液生物标志物动态变化：为期两年的 MAGNIFY-MS 研究结果

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1571978
Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola
神经科学
MAG
多发性硬化症
发表日期：2025
文献求助 收藏

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

克拉屈滨片剂治疗复发型多发性硬化症患者的血液生物标志物动态变化：为期2年的MAGNIFY-MS研究结果

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1512189
Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola
神经科学
MAG
多发性硬化症
发表日期：2025
文献求助 收藏

Neurofilament heavy chain in secondary progressive multiple sclerosis

继发性进行性多发性硬化症中的神经丝重链

期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585241311212
De Angelis, Floriana; Ammoscato, Francesca; Parker, Richard A; Plantone, Domenico; Doshi, Anisha; John, Nevin A; Williams, Thomas; Stutters, Jonathan; MacManus, Dave; Schmierer, Klaus; Barkhof, Frederik; Weir, Christopher J; Giovannoni, Gavin; Chataway, Jeremy; Gnanapavan, Sharmilee
神经科学
多发性硬化症
发表日期：2025
文献求助 收藏

Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study

研究概要：克拉屈滨片治疗复发型多发性硬化症患者的血液生物标志物动态变化：为期两年的 MAGNIFY-MS 研究结果

期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-025-00782-2
Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola
神经科学
MAG
多发性硬化症
发表日期：2025
文献求助 收藏

Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

克拉屈滨治疗复发型多发性硬化症的临床和机制效应：MAGNIFY-MS 研究的 2 年结果

期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864251351760
Schmierer, Klaus; Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Sponton, Laura; Chudecka, Anita; Gardner, Lidia; De Stefano, Nicola
神经科学
MAG
多发性硬化症
发表日期：2025
文献求助 收藏

Effects of cladribine on intrathecal and peripheral B and plasma cells

克拉屈滨对鞘内和外周B细胞及浆细胞的影响

期刊:Clinical and Experimental Immunology
影响因子:3.8
doi:10.1093/cei/uxae116
Allen-Philbey, Kimberley; Stephenson, Sophie; Doody, Gina; MacDougall, Amy; Aboulwafaali, Mohammad; Ammoscato, Francesca; Andrews, Michael; Gnanapavan, Sharmilee; Giovannoni, Gavin; Grigoriadou, Sofia; Hickey, Alaco; Holden, David W; Lock, Helen; Papachatzaki, Maria; Redha, Iman; Baker, David; Tooze, Reuben; Schmierer, Klaus
B细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets: A MAGNIFY-MS Substudy

免疫细胞动力学的特定模式可能解释克拉屈滨片剂的早期起效和持久疗效：一项 MAGNIFY-MS 子研究

期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000200048
Wiendl, Heinz; Schmierer, Klaus; Hodgkinson, Suzanne; Derfuss, Tobias; Chan, Andrew; Sellebjerg, Finn; Achiron, Anat; Montalban, Xavier; Prat, Alexandre; De Stefano, Nicola; Barkhof, Frederik; Leocani, Letizia; Vermersch, Patrick; Chudecka, Anita; Mwape, Claire; Holmberg, Kristina H; Boschert, Ursula; Roy, Sanjeev
MAG
细胞生物学
多发性硬化症
免疫/内分泌
发表日期：2023
文献求助 收藏

Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination

接种疫苗后血清检测呈阴性的多发性硬化症患者感染新冠病毒的风险

期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585231185247
Zaloum, Safiya A; Wood, Callum H; Tank, Pooja; Upcott, Mae; Vickaryous, Nicola; Anderson, Valerie; Baker, David; Chance, Randy; Evangelou, Nikos; George, Katila; Giovannoni, Gavin; Harding, Katharine E; Hibbert, Aimee; Ingram, Gillian; Jolles, Stephen; Kang, Angray S; Loveless, Samantha; Moat, Stuart J; Richards, Aidan; Robertson, Neil P; Rios, Francesca; Schmierer, Klaus; Willis, Mark; Dobson, Ruth; Tallantyre, Emma C
新冠
炎症/感染
神经科学
多发性硬化症
微生物学
发表日期：2023
文献求助 收藏

Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis

克拉屈滨治疗4.5年后疾病活动度：264例多发性硬化症患者的经验

期刊:Therapeutic Advances in Neurological Disorders
影响因子:4.1
doi:10.1177/17562864231200627
Allen-Philbey, Kimberley; De Trane, Stefania; MacDougall, Amy; Adams, Ashok; Bianchi, Lucia; Campion, Thomas; Giovannoni, Gavin; Gnanapavan, Sharmilee; Holden, David W; Marta, Monica; Mathews, Joela; Turner, Benjamin P; Baker, David; Schmierer, Klaus
神经科学
多发性硬化症
发表日期：2023
文献求助 收藏

Parakinesia Brachialis Oscitans in a Patient With a First Manifestation of Multiple Sclerosis

多发性硬化症首发患者出现肱肌运动障碍

期刊:Neurology-Clinical Practice
影响因子:3.2
doi:10.1212/CPJ.0000000000200204
Salavisa, Manuel; Mohamed, Bader; Allen-Philbey, Kimberley; Stennett, Andrea M; Campion, Thomas; Schmierer, Klaus
神经科学
多发性硬化症
发表日期：2023
文献求助 收藏